Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Actavis image

Actavis snaps up Warner Chilcott

May 22, 2013 Research and Development, Sales and Marketing Actavis, Warner Chilcott

Actavis is to buy Dublin-based firm Warner Chilcott in an $8.5 billion deal which will see the Warner name disappear …
News
ABPI image

ABPI takes on vaccine industry brief

May 22, 2013 Research and Development ABPI, vaccines

The ABPI is to take on responsibility for representing the vaccine industry to UK government and healthcare stakeholders.For more than …
News
pfizerworld

Pfizer abandons cancer trial

May 22, 2013 Research and Development, Sales and Marketing Cancer, Inotuzumab ozogamicin, Pfizer, oncology

Pfizer’s oncology pipeline has suffered a blow with the company abandoning a Phase III study of one of its investigational …
News
wefwefwefw

Board changes at Boehringer Ingelheim

May 22, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, baiker

Boehringer’s Professor Wolfram Carius is stepping down from the Board to be replaced by Dr Wolfgang Baiker. Carius who is …
Appointment
eisai_ricardo_gonzalez_-balboa-90-2-1368715273mr

New general manager for Eisai in Mexico

May 21, 2013 Manufacturing and Production, Research and Development, Sales and Marketing

Eisai has appointed Ricardo Gonzalez Balboa to the position of general manager, Eisai Mexico. In this position, Gonzalez Balboa will …
Appointment
NHS image

Working with the NHS in austerity

May 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, atkin, austerity, reforms, wellards

The National Health Service, perhaps the UK’s most deeply loved institution, is facing a double threat. On one hand, there …
Feature

Promise for Lundbeck and Takeda’s depression drug

May 20, 2013 Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly

Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …
News
kela-madar

Biotec Services expands presence in Israel

May 20, 2013 Research and Development, Sales and Marketing Biotec

Clinical supplies firm Biotec Services International has expanded its presence in Israel with the appointment of a new Israeli agent. …
Appointment
rawlins_nice

NICE chairman joins biotech Board

May 17, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Intra-Cellular Therapies, NICE, Rawlins

Biotech firm Intra-Cellular Therapies has appointed former NICE chairman Professor Sir Michael Rawlins to its Board of directors. Rawlins was …
Appointment
Elan image

Elan signs $1 billion finance deal with Theravance

May 15, 2013 Research and Development, Sales and Marketing Elan, Theravance, royalty pharma

Elan has struck a novel deal with Theravance which gives it a share of potential future royalties from its respiratory …
News
sumant_hospira__033retoucha

Hospira Reappoints chief scientific officer

May 15, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Hospira

Injectable drugs and infusion tech firm Hospira has announced that Sumant Ramachandra has been reappointed to his role as senior …
Appointment
Pfizer image

Pfizer targets Newcastle

May 15, 2013 Research and Development, Sales and Marketing ABPI, Cameron, NHS, Newcastle, Pfizer

Pfizer has earmarked Newcastle Hospitals NHS Foundation Trust as one of 60 sites worldwide to take part in a key …
News

Optimer Pharmaceuticals appoints chief operating officer

May 14, 2013 Manufacturing and Production, Research and Development, Sales and Marketing

Biopharma firm Optimer Pharmaceuticals has announced the appointment of Eric Sirota as chief operating officer.  “Eric has tremendous experience and …
Appointment
EMA image

EMA ponders biosimilar guideline

May 14, 2013 Research and Development, Sales and Marketing EMA, biosimilars

The European Medicines Agency is thinking about changes to its guidance on similar biological medicines and has published a draft …
News
Lilly image

Lilly takes $30m hit

May 13, 2013 Research and Development, Sales and Marketing enzastaurin, lilly

Eli Lilly has taken a $30 million hit after abandoning late-stage development of its investigational cancer drug enzastaurin. The compound …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026